Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices
Silvia Graziano, Luca Anzillotti, Giulio Mannocchi, et al.
Journal of Pharmaceutical and Biomedical Analysis (2018) Vol. 163, pp. 170-179
Closed Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

New psychoactive substances: a review and updates
Abu Shafi, Alex J. Berry, Harry Sumnall, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 246
Chemical classification of new psychoactive substances (NPS)
Félix Zapata, José Manuel Matey, Gemma Montalvo, et al.
Microchemical Journal (2020) Vol. 163, pp. 105877-105877
Closed Access | Times Cited: 50
New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
Stefania Chiappini, Alessio Mosca, Andrea Miuli, et al.
Medicina (2021) Vol. 57, Iss. 6, pp. 580-580
Open Access | Times Cited: 48
Identification of new psychoactive substances and their metabolites using non-targeted detection with high-resolution mass spectrometry through diagnosing fragment ions/neutral loss analysis
José Manuel Matey, Félix Zapata, Luis Manuel Menéndez-Quintanal, et al.
Talanta (2023) Vol. 265, pp. 124816-124816
Closed Access | Times Cited: 20
A Comprehensive HPLC–MS-MS Screening Method for 77 New Psychoactive Substances, 24 Classic Drugs and 18 Related Metabolites in Blood, Urine and Oral Fluid
Annagiulia Di Trana, Giulio Mannocchi, Filippo Pirani, et al.
Journal of Analytical Toxicology (2020) Vol. 44, Iss. 8, pp. 769-783
Open Access | Times Cited: 41
Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
Vidyasagar Naik Bukke, Archana Moola, Rosanna Villani, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 965-965
Open Access | Times Cited: 40
Challenges in Drug Surveillance: Strengthening the Analysis of New Psychoactive Substances by Harmonizing Drug Checking Services in Proficiency Testing
Margot Balcaen, Mireia Ventura, Cristina Gil, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4628-4628
Open Access | Times Cited: 13
Monitoring new psychoactive substances use through wastewater analysis: current situation, challenges and limitations
Lubertus Bijlsma, Alberto Celma, Francisco J. López, et al.
Current Opinion in Environmental Science & Health (2019) Vol. 9, pp. 1-12
Open Access | Times Cited: 42
Biomedical analysis of New Psychoactive Substances (NPS) of natural origin
Alfredo Fabrizio Lo Faro, Annagiulia Di Trana, Nunzia La Maida, et al.
Journal of Pharmaceutical and Biomedical Analysis (2019) Vol. 179, pp. 112945-112945
Closed Access | Times Cited: 41
Handheld Raman Spectroscopy in the First UK Home Office Licensed Pharmacist-Led Community Drug Checking Service
Anthony Mullin, M.L. Scott, Giorgia Vaccaro, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 4793-4793
Open Access | Times Cited: 12
New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions
Chinaza Godswill Awuchi, Patrick Maduabuchi Aja, Nancy Bonareri Mitaki, et al.
Journal of Chemistry (2023) Vol. 2023, pp. 1-36
Open Access | Times Cited: 11
Combined colorimetric and electrochemical screening method using 3D printed devices: Towards the selective detection of MDMA in forensic samples
Larissa M.A. Melo, Lucas V. de Faria, Luciano C. Arantes, et al.
Electrochimica Acta (2024) Vol. 483, pp. 144041-144041
Closed Access | Times Cited: 4
Blood and derivatives in NPS detection: Current insights and future challenges
Luana M. Rosendo, Ana Y. Simão, Ana Teresa Brinca, et al.
Comprehensive analytical chemistry (2025)
Closed Access
Emerging substance abuse trends in Jammu & Kashmir: shifts, forensic challenges and strategic responses
Sami Ullah, Fazlullah Khan
Forensic Research & Criminology International Journal (2025) Vol. 13, Iss. 1, pp. 21-28
Open Access
Tackling the sensitive detection of new psychoactive substances by electroanalytical methods
Mihaela Tertiş, Andreea Cernat, Oana Hosu, et al.
Comprehensive analytical chemistry (2025)
Closed Access
Sensors for the detection of new psychoactive substances (NPS)
Morgan Alonzo, Shanlin Fu
Comprehensive analytical chemistry (2025)
Closed Access
Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
Katharina Elisabeth Grafinger, Matthias E. Liechti, Evangelia Liakoni
British Journal of Clinical Pharmacology (2019) Vol. 86, Iss. 3, pp. 429-436
Open Access | Times Cited: 34
Method for the identification and quantification of sixty drugs and their metabolites in postmortem whole blood using liquid chromatography tandem mass spectrometry
Ahmed I. Al‐Asmari
Forensic Science International (2020) Vol. 309, pp. 110193-110193
Closed Access | Times Cited: 29
What the lab can and cannot do: clinical interpretation of drug testing results
Bhushan Kapur, Katarina Aleksa
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 57, Iss. 8, pp. 548-585
Open Access | Times Cited: 29
Sample preparation strategies for the determination of psychoactive substances in biological fluids
Francesc A. Esteve‐Turrillas, Sergio Armenta, Miguel de la Guárdia
Journal of Chromatography A (2020) Vol. 1633, pp. 461615-461615
Closed Access | Times Cited: 28
Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers
Emilia Marchei, Maria Alías-Ferri, Marta Torrens, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4000-4000
Open Access | Times Cited: 24
Current state-of-the-art approaches for mass spectrometry in clinical toxicology: an overview
Frank T. Peters, Daniela Wissenbach
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 8, pp. 487-500
Closed Access | Times Cited: 10
Colorimetric-Electrochemical Combined Method for the Identification of Drugs of Abuse in Blotter Papers: A Powerful Screening Technique Using Three Analytical Responses
Cláudia Mancilha Rocha, Larissa M.A. Melo, Augusto C. C. Santos, et al.
ACS Omega (2025) Vol. 10, Iss. 16, pp. 16648-16657
Open Access
New Psychoactive Substances: A Matter of Time
Flaminia Pantano, Silvia Graziano, Roberta Pacifici, et al.
Current Neuropharmacology (2019) Vol. 17, Iss. 9, pp. 818-822
Open Access | Times Cited: 26
The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
F Negro, Annagiulia Di Trana, Susanna Marinelli
PubMed (2022) Vol. 92, Iss. 6, pp. e2021401-e2021401
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top